| 注册
首页|期刊导航|中草药|萜类成分抗肝纤维化作用及其机制研究进展

萜类成分抗肝纤维化作用及其机制研究进展

杨建展 吴烦 沈东宁 扶婷 刘博 徐方方

中草药2026,Vol.57Issue(18):7110-7123,14.
✕
中草药2026,Vol.57Issue(18):7110-7123,14.DOI:10.7501/j.issn.0253-2670.2026.18.004

萜类成分抗肝纤维化作用及其机制研究进展

Advances on effects of terpenoids against hepatic fibrosis and their mechanisms

杨建展 1吴烦 1沈东宁 1扶婷 1刘博 1徐方方1

作者信息

  • 1. 广州中医药大学第二临床医学院,广东 广州 510120
  • 折叠

摘要

Abstract

Hepatic fibrosis is the pathological consequence of abnormal extracellular matrix deposition in the liver during the self-repair process following chronic injury.Persistent hepatic fibrosis can progress to malignant conditions such as cirrhosis and liver cancer.Currently,no specific therapeutic drugs exist for hepatic fibrosis,therefore,early prevention and intervention are of great significance for delaying disease progression and reducing the incidence of severe liver diseases.In recent years,terpenoids have emerged as a research hotspot due to their significant multi-target and multi-pathway anti-hepatic fibrosis effects.Their mechanisms are associated with anti-inflammation,antioxidative stress,anti-apoptosis,and the regulation of extracellular matrix deposition and degradation.This article systematically reviews natural terpenoids with anti-hepatic fibrosis activity reported in domestic and international literature in recent years,and summarizes their chemical structures and molecular mechanisms,providing a theoretical basis and research perspectives for the research and development of innovative anti-hepatic fibrosis drugs derived from terpenoids.

关键词

肝纤维化/天然药物/齐墩果酸/TGF/Smad信号通路/Nrf2/HO-1信号通路

Key words

hepatic fibrosis/natural drugs/oleanlic acid/TGF/Smad pathway/Nrf2/HO-1 pathway

分类

医药卫生

引用本文复制引用

杨建展,吴烦,沈东宁,扶婷,刘博,徐方方..萜类成分抗肝纤维化作用及其机制研究进展[J].中草药,2026,57(18):7110-7123,14.

基金项目

广东省科技计划项目(2023B1212060062,2023B1212060063) (2023B1212060062,2023B1212060063)

广州市科技局项目(2024A04J9997,2025A03J4085) (2024A04J9997,2025A03J4085)

中草药

0253-2670

访问量0
|
下载量0
段落导航相关论文